<DOC>
	<DOCNO>NCT00362960</DOCNO>
	<brief_summary>Evaluation several olmesartan dosage compare losartan proteinuria , renal function inflammatory marker patient diabetic nephropathy</brief_summary>
	<brief_title>Olmesartan Medoxomil Diabetic Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Proteinuria</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Olmesartan</mesh_term>
	<mesh_term>Olmesartan Medoxomil</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<criteria>Male female European outpatient Greater equal 30 year age Type 2 diabetes first diagnose great equal 30 year age Urinary protein excretion 2004000 mg/day exclusive Mean sit dBP less equal 110 mgHg Medically justifiable withdraw antihypertensive treatment due poor tolerability inefficacy previous treatment , verification treatment still necessary Females pregnant , nurse plan become pregnant childbearing potential use acceptable method contraception Secondary form hypertension diabetic nephropathy , malignant hypertension patient sit dBP exceed 110 mmHg sit sBP exceed 200 mmHg ECG evidence 2nd 3rd degree AVblock , atrial fibrillation , cardiac arrhythmia ( require therapy ) bradycardia Presence significant cardiovascular disease Significant cerebrovascular disease , gastrointestinal , haematological hepatic disease myocardial infarction last 12 month previous history serious underlying disease Concurrent renal disease , nephrectomy and/or renal transplant , serum creatinine level great equal 2.0 mg/dL creatinine clearance CLCR le equal 50 mL/min Clinically significant lab abnormality ( ASAT/SGOT , ALAT/SGPT Î³GT ) Serum potassium level &lt; 2.5 mmol/L &gt; 5.5 mmol/L Treatment concurrent indication drug medication could influence BP History hypersensitivity , lack response contraindication Ang IIantagonists , HCTZ atenolol , hypersensitivity relate drug ( crossallergy )</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Type 2 Diabetes Mellitus</keyword>
	<keyword>Diabetic Nephropathy</keyword>
	<keyword>Inflammatory Markers</keyword>
	<keyword>Proteinuria</keyword>
	<keyword>Renal Disease</keyword>
</DOC>